MMP19
MMP19 (matrix metallopeptidase 19, also known as RASI-1 and previously MMP18) is a secreted endopeptidase of the peptidase M10A family. It degrades components of the extracellular matrix during development, haemostasis and disease. Browse Assay Genie's current range of MMP19 research reagents below, or read on for the biology behind the target.
MMP19 is an endopeptidase that degrades various components of the extracellular matrix. Reported substrates include aggrecan and cartilage oligomeric matrix protein (COMP), and the enzyme also hydrolyses collagen type IV, laminin, nidogen, the tenascin-C isoform, fibronectin and type I gelatin. Through this activity it contributes to matrix turnover during development, haemostasis and pathological conditions such as arthritic disease. It may also play a role in neovascularisation or angiogenesis.
The MMP19 gene encodes a member of the M10 matrix metallopeptidase group, and the protein belongs to the peptidase M10A family. It is secreted into the extracellular space and extracellular matrix as an inactive proprotein, which is activated upon cleavage by extracellular proteases. Alternative splicing of the gene results in multiple transcript variants. The mouse ortholog is Mmp19.
Members of this family break down extracellular matrix in normal physiological processes, including embryonic development, reproduction and tissue remodelling, and in disease processes such as arthritis and metastasis. The protein has also been catalogued as RASI-1, and the gene was formerly designated MMP18 and named matrix metalloproteinase 19. Researchers studying MMP19 therefore often work alongside other matrix metalloproteinases to separate the roles of individual family members in matrix degradation.
MMP19 degrades matrix components including collagen type IV, laminin, nidogen and fibronectin, making it relevant to studies of tissue remodelling.
MMP19 degrades aggrecan and cartilage oligomeric matrix protein, linking it to cartilage turnover in arthritic disease.
MMP19 may play a role in neovascularisation or angiogenesis, which makes it a candidate in vascular biology.
Matrix breakdown by this protease family underlies embryonic development, reproduction and disease processes such as metastasis.
MMP19 is an endopeptidase that degrades extracellular matrix components, including aggrecan, COMP, collagen type IV, laminin, nidogen, fibronectin and type I gelatin. It acts during development, haemostasis and pathological conditions such as arthritic disease, and may also contribute to angiogenesis.
MMP19 is also known as RASI-1, and its previous symbol was MMP18. HGNC lists the full name as matrix metallopeptidase 19, formerly matrix metalloproteinase 19. UniProt names the protein matrix metalloproteinase-19. Alternative splicing gives multiple transcript variants of the gene.
A mouse ortholog, Mmp19, is recorded for this gene. The protein is secreted as an inactive proprotein and is activated when extracellular proteases cleave it. Check the datasheet of any product for its validated reactivity.
Other matrix metalloproteinases and M10 family members involved in extracellular matrix degradation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99542; product specifications from Assay Genie datasheets.